DEVELOPMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL APPS

Recombinant human serum albumin (OsrHSA) has emerged as a significant innovation in the sphere of biopharmaceuticals, presenting promising developments across various healthcare and industrial apps. With its structural similarity to naturally derived human serum albumin, OsrHSA presents a safer, extra trustworthy alternative for therapeutic use, no